Effect of a Global Simplified Strategy on Thromboembolic Events in Emergency Department Patients with Suspected Pulmonary Embolism
MODS STRATEGY
2 other identifiers
interventional
1,223
1 country
1
Brief Summary
Pulmonary embolism (PE) is frequently suspected in emergency departments (ED) patients which often leads to the prescription of DDimer testing and irradiative chest imaging (Computed Tomographic Pulmonary Angiogram CTPA in most cases).\[1\] Indeed, an increased use of CTPA has been reported without clear benefit in terms of prognosis.This increased use is reportedly associated with potential overdiagnosis of PE, increased cost, length of ED stay, and side effects from both chest imaging and undue anticoagulant treatments. The standard diagnostic strategy for PE work up includes three steps with an initial evaluation of clinical probability, followed by D-dimer testing if indicated, followed by chest imaging if necessary - Computed tomographic pulmonary angiogram CTPA being the imaging modality of choice. A large European prospective study has reported that the use of CTPA has constantly increased without change in the diagnostic yield. In order to reduce the use of CTPA, it has been validated that in patients with a low likelihood of PE, the D-dimer threshold for ordering CTPA can be raised at 1000 ng/ml. It has been validated that a low likelihood of PE can be determined either with the YEARS or the PEGeD clinical decision rules. These latter two include one common item being "Is PE the most likely diagnosis". A retrospective cohort study of 3330 patients reported that using this sole question of "Is PE the most likely diagnosis" can be safely used to raise the D-dimer threshold to 1000 ng/ml, and that this performs as well as YEARS and PEGeD. This simple question is easier to use by emergency physicians compared to complex ones, which are reportedly seldom used by emergency physicians. Therefore, the validation of the "PE unlikely" simple and straightforward decision rule could increase physicians' adherence and therefore limit the use of chest imaging. The hypothesis of this prospective study is that the likelihood of PE assessed to elevate the DDimer threshold to 1000 ng/ml can be estimated by the sole question of "is PE the most likely diagnosis", and to validate a global simplified diagnostic strategy for PE in the ED. The intervention will be the patient's management with a simplified global strategy. Whether PE is the most likely diagnostic will be assessed by the unstructured implicit clinician's estimation. In patient with a clinical suspicion of pulmonary embolism: DDimer testing will be performed. If the likelihood of PE is low (PE is not the most likely diagnosis), then threshold for DDimer testing will be 1000 ng/ml. If the likelihood of PE is high (PE is the most likely diagnosis), then the age-adjusted DDimer threshold will be applied.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 19, 2023
CompletedFirst Posted
Study publicly available on registry
January 5, 2024
CompletedStudy Start
First participant enrolled
January 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 21, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 21, 2025
CompletedFebruary 7, 2025
February 1, 2025
1 year
December 19, 2023
February 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The failure proportion of the diagnostic strategy, defined as a diagnosed thrombo-embolic event at 3 months follow-up (either a PE or a deep venous thrombosis), among patients in whom PE was initially ruled out.
3 months
Secondary Outcomes (8)
Pulmonary embolism
3 months
Deep venous thrombosis
3 months
CTPA or V/Q scan ordered by ED physicians
3 months
Type of PE (lobar, segmental, sub-segmental)
3 months
Hospital admission following the ED visit
3 months
- +3 more secondary outcomes
Study Arms (1)
Modified simplified diagnostic strategy MODS
EXPERIMENTALInterventions
The intervention will be the patient's management with a simplified global strategy. Whether PE is the most likely diagnostic will be assessed by the unstructured implicit clinician's estimation. In patient with a clinical suspicion of pulmonary embolism: DDimer testing will be performed. If the likelihood of PE is low (PE is not the most likely diagnosis), then threshold for DDimer testing will be 1000 ng/ml. If the likelihood of PE is high (PE is the most likely diagnosis), then the age-adjusted DDimer threshold will be applied.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- ED adult patients with suspected pulmonary embolism defined as:
- New onset of or worsening shortness of breath
- Or Chest pain
- Or Syncope in the absence of any obvious other cause (such as pneumothorax, asthma attack, ST elevation myocardial infarction, trauma, etc.)
- Patient able to understand and give oral consent
- Informing and obtaining the patient's oral consent
- Social security affiliation (except AME)
You may not qualify if:
- Patients currently treated with full-dose anticoagulant therapy
- Diagnosed thrombo-embolic event in the past 6 months
- PE ruled out by the PERC rule (low clinical probability and none of the 8 items of the PERC score)
- Acute severe presentation (clinical signs of respiratory distress, hypotension, SpO2 \< 90%, shock)
- DDimer level known before ED visit
- Patient living in assisted-living home or nursing home or palliative center. Anticipated life expectancy \< 3 months or "do not resuscitate" order
- Patient under legal protection measure (tutorship or curatorship) and patient deprived of freedom
- Pregnancy and breastfeeding
- Participation in another interventional trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Emergency department Hospital Pitié-Salpêtrière
Paris, 75013, France
Related Publications (1)
Roussel M, Bannelier H, Lebal S, Kassasseya C, Bouzid D, Peyrony O, Baud A, Chauvin A, Beauvais A, Javaud N, Gorlicki J, Truchot J, Le Borgne P, Chocron R, Simon T, Freund Y. D-Dimer thresholds for diagnosis of pulmonary embolism based on a single question: is it the most likely diagnosis? A prospective, multicentre, open-label, single-arm interventional study. Lancet Respir Med. 2026 Jan;14(1):29-37. doi: 10.1016/S2213-2600(25)00292-9. Epub 2025 Oct 21.
PMID: 41135553DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Héloïse BANNELIER, MD, MSc
Assistance Publique - Hôpitaux de Paris
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 19, 2023
First Posted
January 5, 2024
Study Start
January 19, 2024
Primary Completion
January 21, 2025
Study Completion
January 21, 2025
Last Updated
February 7, 2025
Record last verified: 2025-02